
Chemical and Pharmaceutical Bulletin p. 1462 - 1469 (1992)
Update date:2022-08-04
Topics:
Iguchi
Iwamura
Nishizaki
Hayashi
Senokuchi
Kobayashi
Sakaki
Hachiya
Ichioka
Kawamura
A novel, highly cardioselective ultra short-acting β-blocker, ONO-1101, has been developed for application in the emergency treatment of tachycardia and better control of heart rate in surgery. This agent is approximately nine times more potent in β-blocking activity in vivo and eight times more cardioselective in vitro than esmolol. This β-blocking drug has a short duration of activity, enabling rapid recovery after cessation of administration if side effects occur. It can be used safely in patients suffering from acute heart disease and represents a major therapeutic advance in the treatment of heart disease.
View MoreTianjin Bright Future Technology Co., Ltd
Contact:0086-22-58016666
Address:NO.136 DongTeng Lake Street Tianjin Economic and Technology Development Area,Tainjin,China
Jinan Jinguilin Chemical Co.,Ltd
Contact:+86-531-81188412
Address:3rd floor of Torch Building, Huanyuan Rd, City of Jinan
Shanghai Pengkai Chemical Co.,Ltd
Contact:+86-21-60526671
Address:No.4226 Duzhuang Rd Minhang District Shanghai China
Shandong LuZhou Amino Acid Co., Ltd
Contact:86-539-2218025
Address:yishui economic and technical development zone zhenxing south road
SHANDONG CREDAGRI CHEMICAL CO., LTD.
Contact:+86-531-88872050
Address:ROOM 601A, BUILDING 2, SHUNTAI SQUARE, NO. 2000 SHUNHUA ROAD, HI-TECH DEVELOPMENT ZONE, JINAN, CHINA.
Doi:10.1134/S1070428013050138
(2013)Doi:10.1016/S0040-4039(01)85496-4
(1976)Doi:10.1039/c4ra03254c
(2014)Doi:10.1002/hlca.19760590739
(1976)Doi:10.1246/bcsj.49.3193
(1976)Doi:10.1016/S0040-4039(00)88734-1
(1990)